Barr Pharmaceuticals, Inc.
400 Chestnut Ridge Road
Woodcliff Lake
New Jersey
07677
United States
Tel: 201-930-3300
Fax: 201-930-3330
Website: http://www.barrlabs.com/
175 articles about Barr Pharmaceuticals, Inc.
-
Bayer HealthCare Sues Teva Pharmaceutical Industries Limited and Barr Pharmaceuticals, Inc. for False Advertising and Patent Infringement in Connection with Teva's Generic Oral Contraceptive Gianvi(TM)
6/16/2010
-
Endo Pharmaceuticals and Penwest Pharmaceutical Enter Into Agreement with Barr Pharmaceuticals, Inc. to Settle Patent Litigation Over Opana(R) ER
4/13/2010
-
Cephalon, Inc., Barr Pharmaceuticals, Inc. Settle Patent Infringement Suit
11/13/2009
-
Watson Pharmaceuticals, Inc. and Barr Pharmaceuticals, Inc. Settle Lawsuit Over Oxytrol(R)
10/28/2009
-
FDA to OK Barr Pharmaceuticals, Inc.'s Morning-after Pill Plan B for 17-Year-Olds
4/23/2009
-
BioReliance Corporation Announces Agreement with Barr Pharmaceuticals, Inc. to Supply Bulk Virus for the Manufacture of Adenovirus Vaccine for the U.S. Department of Defense
1/6/2009
-
Warner Chilcott and Barr Pharmaceuticals, Inc. Announce Settlement of Femcon(R) Fe Patent Challenge
12/23/2008
-
Teva Pharmaceutical Industries Limited and Barr Pharmaceuticals, Inc. Receive European Commission Approval For Acquisition
12/22/2008
-
Teva Pharmaceutical Industries Limited And Barr Pharmaceuticals, Inc. Receive European Commission Approval for Acquisition
12/19/2008
-
Barr Pharmaceuticals, Inc.'s BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA
12/11/2008
-
Teva Pharmaceutical Industries Limited Draws on $1.75 Billion Bridge Financing in Connection with Pending Barr Pharmaceuticals, Inc. Acquisition
12/8/2008
-
EU Extends Review of Teva Pharmaceutical Industries Limited Bid for Barr Pharmaceuticals, Inc.
12/2/2008
-
Barr Pharmaceuticals, Inc. Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg
12/1/2008
-
Cephalon, Inc. and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals, Inc. and Barr Pharmaceuticals, Inc.
11/26/2008
-
Watson Pharmaceuticals, Inc. Gains 17 Generic Drugs from Teva Pharmaceutical Industries Limited-Barr Pharmaceuticals, Inc. Deal; Watson to Pay $36 Million for the Portfolio
11/25/2008
-
Sanofi-Aventis (France) Settles Allergy Drugs Dispute; Barr Pharmaceuticals, Inc. Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges
11/19/2008
-
Barr Pharmaceuticals, Inc. Reports Third Quarter 2008 GAAP Earnings of $0.28 Per Share; Adjusted Earnings of $0.83 Per Share
11/6/2008
-
Barr Pharmaceuticals, Inc. Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL
11/3/2008
-
Teva Pharmaceutical Industries Limited And Barr Pharmaceuticals, Inc. Provide Update on Acquisition
10/28/2008
-
Teva Pharmaceutical Industries Limited (JOBS) Purchase of Barr Pharmaceuticals, Inc. on Track After Funding Deal
10/28/2008